Hla B*5701 Status - Pharma

Relevant Publications

Prevalence of the HLA-B*5701 Allele and Abacavir Hypersensitivity in Saudi HIV Patients: A Multicenter Study.

Issue Release: 2023

Clinical parameters, selected HLA and chemokine gene variants associated with late presentation into care of people living with HIV/AIDS.

Issue Release: 2021

The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single-tablet regimen in the expanding spectrum of fixed-dose combination therapy for HIV.

Issue Release: 2020

Low prevalence of human leukocyte antigen-B*5701 in HIV-1-infected Chinese subjects: a prospective epidemiological investigation.

Issue Release: 2015

HLA B*5701 status, disease progression, and response to antiretroviral therapy.

Issue Release: 2013

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

Issue Release: 2012

Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.

Issue Release: 2009

Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir?

Issue Release: 2009

Clinical use of pharmacogenomic tests in 2009.

Issue Release: 2009

Pharmacogenetics: implementing personalized medicine.

Issue Release: 2009

The HLA-B/-C haplotype block contains major determinants for host control of HIV.

Issue Release: 2009

[Prospective validation of a pharmacogenetic test: the PREDICT-1 study].

Issue Release: 2008

External quality assessment of HLA-B*5701 reporting: an international multicentre survey.

Issue Release: 2007

Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses.

Issue Release: 2007

Why are Collaborative Care Models Important in Pharma?

What Role Does Technology Play?

Why is Geriatric Care Important?

How are ADEs Different from Side Effects?

How are ADEs Detected and Reported?

How Are Participants Protected?

What are the Regulatory Requirements for Generic Drugs?

How Can Technology Aid in Management?

How Does the Patent System Affect Generic Competition?

What is Medication Management?

Partnered Content Networks

Relevant Topics